These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 28297794)

  • 1. [Research advances in autoimmune liver diseases in 2016].
    Li B; Wang QX; Ma X
    Zhonghua Gan Zang Bing Za Zhi; 2017 Feb; 25(2):100-104. PubMed ID: 28297794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Research advances of autoimmune liver diseases in 2018].
    Chen Y; Wang QX; Ma X
    Zhonghua Gan Zang Bing Za Zhi; 2019 Jan; 27(1):14-17. PubMed ID: 30685918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Autoimmune liver diseases and their overlap syndromes].
    Strassburg CP
    Praxis (Bern 1994); 2006 Sep; 95(36):1363-81. PubMed ID: 16989180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UPDATE OF THE BRAZILIAN SOCIETY OF HEPATOLOGY RECOMMENDATIONS FOR DIAGNOSIS AND MANAGEMENT OF AUTOIMMUNE DISEASES OF THE LIVER.
    Couto CA; Terrabuio DRB; Cançado ELR; Porta G; Levy C; Silva AEB; Bittencourt PL; ; Carvalho Filho RJ; Chaves DM; Miura IK; Codes L; Faria LC; Evangelista AS; Farias AQ; Gonçalves LL; Harriz M; Lopes EPA; Luz GO; Oliveira PMC; Oliveira EMG; Schiavon JLN; Sevá-Pereira T
    Arq Gastroenterol; 2019 Aug; 56(2):232-241. PubMed ID: 31460591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Novel Insights of Primary Sclerosing Cholangitis and Primary Biliary Cholangitis].
    Ahn DW
    Korean J Gastroenterol; 2020 May; 75(5):246-256. PubMed ID: 32448856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in Incidence of Autoimmune Liver Diseases and Increasing Incidence of Autoimmune Hepatitis.
    Lamba M; Ngu JH; Stedman CAM
    Clin Gastroenterol Hepatol; 2021 Mar; 19(3):573-579.e1. PubMed ID: 32526342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Autoimmune liver diseases].
    Fischer HP; Goltz D
    Pathologe; 2020 Sep; 41(5):444-456. PubMed ID: 32749523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood.
    Maggiore G; Riva S; Sciveres M
    Minerva Gastroenterol Dietol; 2009 Mar; 55(1):53-70. PubMed ID: 19212308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variant and Specific Forms of Autoimmune Cholestatic Liver Diseases.
    Dalekos GN; Gatselis NK
    Arch Immunol Ther Exp (Warsz); 2019 Aug; 67(4):197-211. PubMed ID: 31165900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Epidemiology of UK Autoimmune Liver Disease Varies With Geographic Latitude.
    Webb GJ; Ryan RP; Marshall TP; Hirschfield GM
    Clin Gastroenterol Hepatol; 2021 Dec; 19(12):2587-2596. PubMed ID: 33493696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ulcerative colitis complicated by autoimmune hepatitis-primary biliary cholangitis-primary sclerosing cholangitis overlap syndrome.
    Jing M; Zhang W; Xia M
    Rev Esp Enferm Dig; 2022 Dec; 114(12):765-766. PubMed ID: 36205327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twenty-Year Comparative Analysis of Patients With Autoimmune Liver Diseases on Transplant Waitlists.
    Webb GJ; Rana A; Hodson J; Akhtar MZ; Ferguson JW; Neuberger JM; Vierling JM; Hirschfield GM
    Clin Gastroenterol Hepatol; 2018 Feb; 16(2):278-287.e7. PubMed ID: 28993258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and therapeutic questions in overlap syndromes of autoimmune hepatitis.
    Premoli A; Morello E; Bo S; Durazzo M
    Minerva Gastroenterol Dietol; 2007 Mar; 53(1):79-82. PubMed ID: 17415345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune cholangitis.
    Sherlock S
    Clin Liver Dis; 2000 Feb; 4(1):97-113. PubMed ID: 11232193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive assessment of ECM turnover using serum biomarkers establishes PBC as a high-turnover autoimmune liver disease.
    Vesterhus M; Nielsen MJ; Hov JR; Saffioti F; Manon-Jensen T; Leeming DJ; Moum B; Boberg KM; Pinzani M; Karlsen TH; Karsdal MA; Thorburn D
    JHEP Rep; 2021 Feb; 3(1):100178. PubMed ID: 33225252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of complement activation in autoimmune liver disease.
    Biewenga M; Farina Sarasqueta A; Tushuizen ME; de Jonge-Muller ESM; van Hoek B; Trouw LA
    Autoimmun Rev; 2020 Jun; 19(6):102534. PubMed ID: 32234403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence of primary sclerosing cholangitis, primary biliary cholangitis and auto-immune hepatitis after liver transplantation.
    Visseren T; Darwish Murad S
    Best Pract Res Clin Gastroenterol; 2017 Apr; 31(2):187-198. PubMed ID: 28624107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obeticholic acid for the treatment of primary biliary cholangitis.
    Ali AH; Lindor KD
    Expert Opin Pharmacother; 2016 Sep; 17(13):1809-15. PubMed ID: 27468093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic models and autoimmune liver diseases.
    D'Amato D; Carbone M
    Best Pract Res Clin Gastroenterol; 2023 Dec; 67():101878. PubMed ID: 38103932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Autoimmune hepatitis and overlap syndrome: diagnosis].
    Berg PA; Klein R
    Praxis (Bern 1994); 2002 Aug; 91(34):1339-46. PubMed ID: 12233264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.